Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells
dc.contributor.author | Joe, Andrew K. | en_US |
dc.contributor.author | Liu, Hui | en_US |
dc.contributor.author | Xiao, Danhua | en_US |
dc.contributor.author | Soh, Jae-Won | en_US |
dc.contributor.author | Pinto, John T. | en_US |
dc.contributor.author | Beer, David G. | en_US |
dc.contributor.author | Piazza, Gary A. | en_US |
dc.contributor.author | Joseph Thompson, W. | en_US |
dc.contributor.author | Bernard Weinstein, I. | en_US |
dc.date.accessioned | 2010-06-01T22:28:47Z | |
dc.date.available | 2010-06-01T22:28:47Z | |
dc.date.issued | 2003-03 | en_US |
dc.identifier.citation | Joe, Andrew K.; Liu, Hui; Xiao, Danhua; Soh, Jae-Won; Pinto, John T.; Beer, David G.; Piazza, Gary A.; Joseph Thompson, W.; Bernard Weinstein, I. (2003). "Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells." Journal of Experimental Therapeutics and Oncology 3(2): 83-94. <http://hdl.handle.net/2027.42/75468> | en_US |
dc.identifier.issn | 1359-4117 | en_US |
dc.identifier.issn | 1533-869X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75468 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12822514&dopt=citation | en_US |
dc.format.extent | 2229495 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | Blackwell Publishing Inc. 2003 | en_US |
dc.subject.other | Barrett's Esophagus | en_US |
dc.subject.other | Chemoprevention | en_US |
dc.subject.other | CP248 | en_US |
dc.subject.other | Exisulind | en_US |
dc.title | Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI, and | en_US |
dc.contributor.affiliationother | Herbert Irving Comprehensive Cancer Center, | en_US |
dc.contributor.affiliationother | Department of Medicine, College of Physicians & Surgeons of Columbia University, New York, NY | en_US |
dc.contributor.affiliationother | American Health Foundation, Valhalla, NY, | en_US |
dc.contributor.affiliationother | Cell Pathways, Inc., Horsham, PA, U.S.A. | en_US |
dc.identifier.pmid | 12822514 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75468/1/j.1359-4117.2003.01076.x.pdf | |
dc.identifier.doi | 10.1046/j.1359-4117.2003.01076.x | en_US |
dc.identifier.source | Journal of Experimental Therapeutics and Oncology | en_US |
dc.identifier.citedreference | Riddell RH. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol 91: 853 – 863, 1996. | en_US |
dc.identifier.citedreference | Rusch VW, Levine DS, Haggitt R, Reid BJ. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 74: 1225 – 1229, 1994. | en_US |
dc.identifier.citedreference | Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593 – 1596, 1991. | en_US |
dc.identifier.citedreference | Goldberg Y, Nassif II, Pittas A, Tsai LL, Dynlacht BD, Rigas B, Shiff SJ. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene, 12: 893 – 901, 1996. | en_US |
dc.identifier.citedreference | Piazza GA, Alberts DS, Hixson LJ, et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 57: 2909 – 2915, 1997. | en_US |
dc.identifier.citedreference | Lim JT, Piazza GA, Han EK, et al. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol 58: 1097 – 1107, 1999. | en_US |
dc.identifier.citedreference | Piazza GA, Rahm AL, Krutzsch M, et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110 – 3116, 1995. | en_US |
dc.identifier.citedreference | Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 57: 267 – 271, 1997. | en_US |
dc.identifier.citedreference | Han EK, Arber N, Yamamoto H, et al. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 48: 195 – 203, 1998. | en_US |
dc.identifier.citedreference | Rahman MA, Dhar DK, Masunaga R, Yamanoi A, Kohno H, Nagasue N. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res 60: 2085 – 2089, 2000. | en_US |
dc.identifier.citedreference | Thompson WJ, Piazza GA, Li H, et al. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 60: 3338 – 3342, 2000. | en_US |
dc.identifier.citedreference | Soh JW, Mao Y, Kim MG, Pamukcu R, Li H, Piazza GA, Thompson WJ, Weinstein IB. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res 6: 4136 – 4141, 2000. | en_US |
dc.identifier.citedreference | Soh JW, Mao Y, Liu L, Thompson WJ, Pamukcu R, Weinstein IB. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J Biol Chem 276: 16406 – 16410, 2001. | en_US |
dc.identifier.citedreference | Yoon J-T, Palazzo AF, Xiao D, et al. CP248, a derivative of Exisulind, causes growth inhibition, mitotic arrest and abnormalities in microtubule polymerization in glioma cells. Mol Cancer Ther 1: 393 – 404, 2002. | en_US |
dc.identifier.citedreference | Goluboff ET, Shabsigh A, Saidi JA, et al. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology 53: 440 – 445, 1999. | en_US |
dc.identifier.citedreference | van Stolk R, Stoner G, Hayton WL, et al. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res 6: 78 – 89, 2000. | en_US |
dc.identifier.citedreference | Soriano AF, Helfrich B, Chan DC, Heasley LE, Bunn PA Jr, Chou TC. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res 59: 6178 – 6184, 1999. | en_US |
dc.identifier.citedreference | Banks-Schlegel SP, Quintero J. Growth and differentiation of human esophageal carcinoma cell lines. Cancer Res 46: 250 – 258, 1986. | en_US |
dc.identifier.citedreference | Jiang W, Zhang YJ, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer Proc Natl Acad Sci USA 90: 9026 – 9030, 1993. | en_US |
dc.identifier.citedreference | Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 39 – 51, 1995. | en_US |
dc.identifier.citedreference | Westendorf JM, Rao PN, Gerace L. Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc Natl Acad Sci USA 91: 714 – 718, 1994. | en_US |
dc.identifier.citedreference | Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, Moss SF. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res 59: 2277 – 2281, 1999. | en_US |
dc.identifier.citedreference | Lakritz J, Plopper CG, Buckpitt AR. Validated high-performance liquid chromatography-electrochemical method for determination of glutathione and glutathione disulfide in small tissue samples. Anal Biochem 247: 63 – 68, 1997. | en_US |
dc.identifier.citedreference | Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183 – 1188, 1994. | en_US |
dc.identifier.citedreference | Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276 – 1280, 1997. | en_US |
dc.identifier.citedreference | Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 6: 1229 – 1238, 2000. | en_US |
dc.identifier.citedreference | Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology 118: 487 – 496, 2000. | en_US |
dc.identifier.citedreference | Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56: 5125 – 5127, 1996. | en_US |
dc.identifier.citedreference | Pinto JT, Rivlin RS. Antiproliferative effects of allium derivatives from garlic. J Nutr 131: 1058S – 1060S, 2001. | en_US |
dc.identifier.citedreference | Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156 – 160, 1994. | en_US |
dc.identifier.citedreference | Chen YR, Wang W, Kong AN, Tan TH. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J Biol Chem 273: 1769 – 1775, 1998. | en_US |
dc.identifier.citedreference | van Lieshout EM, Tiemessen DM, Peters WH, Jansen JB. Effects of nonsteroidal anti-inflammatory drugs on glutathione S- transferases of the rat digestive tract. Carcinogenesis 18: 485 – 490, 1997. | en_US |
dc.identifier.citedreference | Shirin H, Pinto JT, Kawabata Y, et al. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res 61: 725 – 731, 2001. | en_US |
dc.identifier.citedreference | Compton KR, Orringer MB, Beer DG. Induction of glutathione s-transferase-pi in Barrett's metaplasia and Barrett's adenocarcinoma cell lines. Mol Carcinog 24: 128 – 136, 1999. | en_US |
dc.identifier.citedreference | Sharma RA. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer. Q J M 95: 267 – 273, 2002. | en_US |
dc.identifier.citedreference | Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 216: 201 – 210, 1997. | en_US |
dc.identifier.citedreference | Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 1946 – 1952, 2000. | en_US |
dc.identifier.citedreference | Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58: 2929 – 2934, 1998. | en_US |
dc.identifier.citedreference | Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen- activated protein kinase pathways. J Biol Chem 275: 14838 – 14845, 2000. | en_US |
dc.identifier.citedreference | Corasaniti MT, Strongoli MC, Piccirilli S, et al. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem Biophys Res Commun 274: 664 – 669, 2000. | en_US |
dc.identifier.citedreference | Gilroy DW, Colville-Nash PR. New insights into the role of COX 2 in inflammation. J Mol Med 78: 121 – 129, 2000. | en_US |
dc.identifier.citedreference | Joldersma M, Klein-Nulend J, Oleksik AM, Heyligers IC, Burger EH. Estrogen enhances mechanical stress-induced prostaglandin production by bone cells from elderly women. Am J Physiol Endocrinol Metab 280: E436 – E442, 2001. | en_US |
dc.identifier.citedreference | Ogasawara A, Arakawa T, Kaneda T, Takuma T, Sato T, Kaneko H, Kumegawa M, Hakeda Y. Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP beta, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem 276: 7048 – 7054, 2001. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.